Marco Merlano - Concepedia

Author

Marco Merlano

Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo ORCID

Also Known As

M Merlano, M. C. Merlano, M. Merlano, M.C. Merlano, MARCO MERLANO, Marco C Merlano, Marco C. Merlano, Marco Carlo Merlano, Marco Merlano, Marco Carlo Merlano

338

Publications

Citations

H-Index

Concepts

All Affiliations

Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo Centre Antoine Lacassagne Imperial College London Alleanza Contro il Cancro Istituti di Ricovero e Cura a Carattere Scientifico

About

Marco Merlano is an author at Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	46	2.1K
2	Health Sciences	12	15	586
3	Cell Biology	6	6	685
4	Arts	1	1	57
5	Allergy	1	1	22

Marco Merlano

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis Daniele Bergamaschi, Milena Gasco, Louise Hiller, Cancer Cell Tumor BiologyOncologyMedicineApoptosisCell Death	2003	456
Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and Radiotherapy Marco Merlano, Vito Vitale, Riccardo Rosso, New England Journal of Medicine	1992	303
Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck Marco Merlano, Marco Benasso, Renzo Corvò, JNCI Journal of the National Cancer Institute	1996	249
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine Gianmauro Numico, Ornella Garrone, Vincenzo Dongiovanni, Cancer	2005	197
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial Michael Henke, A. Fortin, Heikki Minn, The Lancet Oncology Open-label Phase 2Radiation TherapyNeoadjuvant TherapyMedicineAdvanced Squamous-cell Carcinoma	2015	161
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide Mauro Feola, Ornella Garrone, Marcella Occelli, International Journal of Cardiology Heart FailureBrain Natriuretic PeptideMedicineAnthracycline ChemotherapyPharmacology	2009	160
Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy Carmine Pinto, Carlo Barone, Giampiero Girolomoni, The Oncologist	2011	119
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Milena Gasco, Alexandra Bell, Victoria L. Heath, PubMed Epigenetic ChangeEpigenetic InactivationPathologyDna SequencesDermatology	2002	119
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors Francesco Panzuto, Maria Rinzivillo, Nicola Fazio, The Oncologist	2014	102
Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial Marco Merlano, Renzo Corvò, G Margarino, Cancer Neoadjuvant TherapyMetronomic ChemotherapyCt. CtRadiation MedicineOncology	1991	100

Page 1